GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

As the FTSE 100's pharmaceutical giants nervously await possible US tariffs, could trade levies end up impacting NHS users?

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product ... events for bio & pharmaceutical manufacturing ...

The GSK oncology products it has sold on to Novartis were ... is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.